A research team led by Sergiu Pașca at Stanford University has published a groundbreaking study in the prestigious journal Nature. The study details the transplantation of human brain organoids—miniature, simplified versions of brain tissue—into the brains of mice that had been genetically engineered to lack cells in key brain regions. Remarkably, the human cells proliferated extensively, eventually occupying nearly half of the mouse's brain volume. Notably, the mice that received these transplants exhibited improved memory capabilities, suggesting that the human brain tissue actively participated in their cognitive processes. These innovative "xenocortical mice" (mice with human brain tissue) hold significant promise for advancing research into brain injuries and neurological disorders.

This study underscores the immense potential of integrating genetic engineering with stem cell technology to modify and reshape living organisms. Such advancements could pave the way for future treatments for stroke patients and other neurological conditions. However, the research has also ignited intense ethical debates. Pașca has emphasized that, at the current stage of research, there is no risk of rodents developing human-like cognitive abilities. Furthermore, he has expressed his strong opposition to conducting similar experiments on primates, citing ethical considerations.